A. A. Brandes

Discipline

Psychologie (1) Economies et finances (1)

Type de document

Articles (6) Recensions (1)

Co-auteur

Date

Source

Mot-clé

survie (5) Treatment (5) Survival (5) Patients (5) Brain (5) Patients (5) cerveau (5) procès (4) cancer (4) Cancer (4) Radiotherapy (4) Months (4) Human beings (4) Cancer (4) Radiotherapy (4) administration (3) norme (3) danger (3) âge (3) adulte (3) Chemotherapy (3) Methods (3) Ci (Chinese poetry) (3) Tumors (3) State, The (3) Political science (3) Methylation (3) Manufacturers' agents (3) Management (3) Days (3)

Documents écrit par A. A. Brandes (6) | parle de A. A. Brandes (0)

The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.
P. Bady et al.
Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082).
W. Wick et al. (1 oct. 2016)
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
B.G. Baumert et al. (2016)
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group.
R. Stupp et al. (2011)
Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers.
R. Stupp et al. (2008)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R. Stupp et al.